Evaluation the effect of oral zinc sulfate therapy on burning severity in burning mouth syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201312093133N5

Enrollment

Registered

2014-09-26

Start date

2014-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burning mouth syndrom. Unspecified behavioural syndromes associated with physiological disturbances and physical factors

Interventions

Intervention 1: In control group placebo capsules would be given to patients for 3 month. Intervention 2: In intervention group zinc sulfate capsules (220 mg) would be given to patients for 3 mon

Treatment - Drugs

In control group placebo capsules would be given to patients for 3 month

In intervention group zinc sulfate capsules (220 mg) would be given to patients for 3 month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: patients with burning mouth syndrome exclusive criteria : patients with known systemic disease; patients under 18 years; pregnancy; patients with oral denture

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Decreasing of burning Mouth. Timepoint: after 3 months. Method of measurement: Visual analog scale.	—

Secondary

Measure	Time frame
Well being of xerostomia. Timepoint: 3 months. Method of measurement: lent soma.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Arbabi-Kalati

Faculty of dentistery

farbabi@razi.tums.ac.ir+98 54 1241 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026